Found: 1
Select item for more details and to access through your institution.
Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 377, doi. 10.1634/theoncologist.2012-0378
- By:
- Publication type:
- Article